HSCS — HeartSciences Inc.
—
Nasdaq ·
Financials ·
Consumer Finance ·
CIK 1468492 ·
Last close
$2.76
Market Cap
$10.76M
52W High
$3.75
52W Low
$1.63
ADV30
92,850
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Apr 2026 | 0 | 0 | -2,536,405 | -2,750,904 | 5,262,673 | 1,656,814 | 5,036,613 |
| Jan 2026 | 0 | 0 | -1,928,940 | -1,985,208 | 7,554,503 | 3,397,035 | 4,902,380 |
| Oct 2025 | 2,419 | 1,411 | -2,073,403 | -2,350,769 | 5,996,117 | 1,951,103 | 1,813,647 |
| Jul 2025 | 1,900 | 1,140 | -1,874,119 | -2,054,994 | 6,437,186 | 2,792,231 | 3,296,075 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,426,707
Investing CF
$-44,452
Financing CF
$8,029,875
CapEx
$-52,264
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-5.63
As of
2026-07-26
Balance + Analyst (yfinance extras)
Retained Earnings
$-85,269,510
Inventory
$655,629
Receivables
$0
ST Investments
—
EBIT TTM
$-8,388,834
Pretax Income TTM
$-9,141,875
Interest Exp TTM
$753,041
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,319
EBITDA
$-8,385,076
Free Cash Flow
$-2,870,175
Enterprise Value
$13,199,321
Total Cash
$1,656,814
Total Debt
$3,936,647
Shares Out
3,899,491
Trailing EPS
$-3.48
Book Value
$0.07
ROE
-4239.9%
ROA
-110.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Apr 2026 | 4,319 | -8,412,867 | -9,141,875 | 5,262,673 | 5,036,613 | — | -7,426,707 |
| Apr 2025 | 4,350 | -8,352,571 | -8,765,229 | 4,222,909 | 4,017,738 | — | -7,412,994 |
| Apr 2024 | 18,600 | -6,305,770 | -6,605,208 | 9,503,113 | 2,185,812 | — | -6,070,185 |
| Apr 2023 | 5,150 | -6,112,964 | -6,354,290 | 3,287,233 | 3,056,676 | — | -5,773,577 |
| Apr 2022 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$3,800
NetIncome TTM
$-4,109,988
OpCashFlow TTM
$0
Assets (Latest)
$4,222,909
Forward EPS
$-1.86
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VRME | VerifyMe, Inc. | $9.54M | $0.72 | — |
| SPFX | STANDARD PREMIUM FINANCE HOLDINGS, INC. | $8.79M | $3.00 | — |
| CBLO | C2 Blockchain, Inc. | $8.09M | $0.04 | — |
| TRLC | TriLinc Global Impact Fund LLC | $14.64M | $0.80 | — |
| CNF | CNFinance Holdings Ltd. | $15.02M | $2.19 | — |
News headlines (Yahoo Finance, 1h cache)
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
2026-08-19 13:00 · Yahoo
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
2026-07-29 13:00 · Yahoo
Fortitude Energizes 12 MW Grand Island, Nebraska Facility, Expanding Owned-and-Operated Power Portfolio
2026-07-28 11:30 · Yahoo
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
2026-07-23 21:15 · Yahoo
Zcash Miner Fortitude Merging with HeartSciences to Go Public
2026-06-23 20:18 · Yahoo
Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets
2026-06-23 11:30 · Yahoo
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents
2026-06-11 12:30 · Yahoo
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
2026-06-02 12:30 · Yahoo
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
2026-05-05 13:00 · Yahoo
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
2026-04-14 20:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.